) The Community-Based Research Management Core (CBRMC) serves to facilitate investigators' access to community-wide and well-defined population- based resources for study. With a primary objective of facilitating recruitment of research participants, the CBRMC also provides educational curriculum development for lay audiences, survey instrument development and evaluation in a community setting, community networking, and monitoring of compliance to protocol activities. The foundation for the Core comes from 50 years of direct community services, including health education programs and patient services, and 26 years of participation in NCI's Surveillance, Epidemiology and End Results (SEER) population-based cancer registry program. This Core will help investigators identify appropriate populations for study, improve accrual rates through direct access to target populations, improve compliance to research protocols, reduce participant attrition, and provide coordination of tasks for greater efficiency in studies of cancer etiology, treatment, and prevention. The CBRMC is uniquely positioned to provide access to the community at large and to well-defined population-based samples for studies of cancer etiology, treatment and prevention. Core staff with a range of backgrounds and experience, enable the Institute to adapt and target programs and educational activities to meet unique needs within the community. This ability to customize messages for specific populations, together with having well established contacts within the various communities, allows the CBRMC to fully partner in community-based research initiatives, as well as to meet the changing needs and requirements of a comprehensive cancer center.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA022453-23
Application #
6573372
Study Section
Subcommittee E - Prevention &Control (NCI)
Project Start
2001-12-01
Project End
2002-11-30
Budget Start
Budget End
Support Year
23
Fiscal Year
2002
Total Cost
Indirect Cost
Name
Wayne State University
Department
Type
DUNS #
City
Detroit
State
MI
Country
United States
Zip Code
48202
Sexton, Rachel E; Hachem, Ali H; Assi, Ali A et al. (2018) Metabotropic glutamate receptor-1 regulates inflammation in triple negative breast cancer. Sci Rep 8:16008
Campbell, Douglas H; Lund, Maria E; Nocon, Aline L et al. (2018) Detection of glypican-1 (GPC-1) expression in urine cell sediments in prostate cancer. PLoS One 13:e0196017
Saadat, Nadia; Liu, Fangchao; Haynes, Brittany et al. (2018) Nano-delivery of RAD6/Translesion Synthesis Inhibitor SMI#9 for Triple-negative Breast Cancer Therapy. Mol Cancer Ther 17:2586-2597
Cheriyan, Vino T; Alsaab, Hashem; Sekhar, Sreeja et al. (2018) A CARP-1 functional mimetic compound is synergistic with BRAF-targeting in non-small cell lung cancers. Oncotarget 9:29680-29697
Burl, Rayanne B; Ramseyer, Vanesa D; Rondini, Elizabeth A et al. (2018) Deconstructing Adipogenesis Induced by ?3-Adrenergic Receptor Activation with Single-Cell Expression Profiling. Cell Metab 28:300-309.e4
Dedigama-Arachchige, Pavithra M; Acharige, Nuwan P N; Pflum, Mary Kay H (2018) Identification of PP1-Gadd34 substrates involved in the unfolded protein response using K-BIPS, a method for phosphatase substrate identification. Mol Omics 14:121-133
Thakur, Manish K; Ruterbusch, Julie J; Schwartz, Ann G et al. (2018) Risk of Second Lung Cancer in Patients with Previously Treated Lung Cancer: Analysis of Surveillance, Epidemiology, and End Results (SEER) Data. J Thorac Oncol 13:46-53
Desai, Pinkal; Wallace, Robert; Anderson, Matthew L et al. (2018) An analysis of the association between statin use and risk of endometrial and ovarian cancers in the Women's Health Initiative. Gynecol Oncol 148:540-546
Mitrea, Cristina; Wijesinghe, Priyanga; Dyson, Greg et al. (2018) Integrating 5hmC and gene expression data to infer regulatory mechanisms. Bioinformatics 34:1441-1447
Ma, Huiyan; Ursin, Giske; Xu, Xinxin et al. (2018) Body mass index at age 18 years and recent body mass index in relation to risk of breast cancer overall and ER/PR/HER2-defined subtypes in white women and African-American women: a pooled analysis. Breast Cancer Res 20:5

Showing the most recent 10 out of 826 publications